Andrew E Hendifar (Andrew Hendifar)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Neuroendocrine Tumors

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Pamela L Kunz, Noah T Graham, Paul J Catalano, Halla S Nimeiri, George A Fisher, Teri A Longacre, Carlos J Suarez, Brock A Martin, James C Yao, Matthew H Kulke, Andrew E Hendifar, James C Shanks, Manisha H Shah, Mark M Zalupski, Edmond L Schmulbach, Diane L Reidy, Jonathan R Strosberg, Peter J O'Dwyer, Al Bowen Benson
A Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Margherita Ambrosini, Marzia Del Re, Francesco Pantano, Andrew E Hendifar, Alexander E Drilon, Guilherme Harada, Anne Hansen Ree, Samuel J Klempner, Gunhild Mari Mælandsmo, Norman John Carr, Hege G Russnes, James M Cleary, Harshabad Singh, Elisa Sottotetti, Antonia Martinetti, Giovanni Randon, Andrea Sartore-Bianchi, Iolanda Capone, Massimo Milione, Maria Di Bartolomeo, Filippo Pietrantonio
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series. JCO precision oncology 6 (2022)
Arjun Gupta, Omar Khalid, Cassadie Moravek, Anica Lamkin, Lynn M Matrisian, Sudheer Doss, Crystal S Denlinger, Andrew L Coveler, Colin D Weekes, Eric J Roeland, Andrew E Hendifar, Ryan D Nipp
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience. Cancer medicine 10 (20) (2021)